{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1360011144136815744.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.3109/07853890.2011.560181"}},{"identifier":{"@type":"URI","@value":"http://www.tandfonline.com/doi/pdf/10.3109/07853890.2011.560181"}}],"dc:title":[{"@value":"A novel approach to control hyperglycemia in type 2 diabetes: Sodium glucose co-transport (SGLT) inhibitors. Systematic review and meta-analysis of randomized trials"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1380011144136815746","@type":"Researcher","foaf:name":[{"@value":"Giovanni Musso"}]},{"@id":"https://cir.nii.ac.jp/crid/1380011144136815744","@type":"Researcher","foaf:name":[{"@value":"Roberto Gambino"}]},{"@id":"https://cir.nii.ac.jp/crid/1380011144136815747","@type":"Researcher","foaf:name":[{"@value":"Maurizio Cassader"}]},{"@id":"https://cir.nii.ac.jp/crid/1380011144136815745","@type":"Researcher","foaf:name":[{"@value":"Gianfranco Pagano"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"07853890"},{"@type":"EISSN","@value":"13652060"}],"prism:publicationName":[{"@value":"Annals of Medicine"}],"dc:publisher":[{"@value":"Informa UK Limited"}],"prism:publicationDate":"2011-04-15","prism:volume":"44","prism:number":"4","prism:startingPage":"375","prism:endingPage":"393"},"reviewed":"false","url":[{"@id":"http://www.tandfonline.com/doi/pdf/10.3109/07853890.2011.560181"}],"createdAt":"2011-04-15","modifiedAt":"2017-06-19","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360004238534692224","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Switching Dipeptidyl Peptidase-4 Inhibitors to Tofogliflozin, a Selective Inhibitor of Sodium-Glucose Cotransporter 2 Improve Arterial Stiffness Evaluated by Cardio-Ankle Vascular Index in Patients with Type 2 Diabetes: A Pilot Study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021390768031872","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Comparison of Effectiveness Among Different Sodium‐Glucose Cotransoporter‐2 Inhibitors According to Underlying Conditions: A Network Meta‐Analysis of Randomized Controlled Trials"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285714914577920","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Management of Diabetes Associated with Nephrotic Syndrome: Therapeutic Potential of Dapagliflozin for Protracted Volume Retention"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567181110179840","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Fructose and uric acid in diabetic nephropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567182220095616","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Renal protection by sodium-glucose cotransporter 2 inhibitors and its underlying mechanisms in diabetic kidney disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360585257123633280","@type":"Article","resourceType":"preprint","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Reduction of susceptibility to azoles and 5-fluorocytosine and growth acceleration in\n                  <i>Candida albicans</i>\n                  by glucose in urine"}]},{"@id":"https://cir.nii.ac.jp/crid/1360857593801156352","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Reduction of susceptibility to azoles and 5-fluorocytosine and growth acceleration in Candida albicans in glucosuria"}]},{"@id":"https://cir.nii.ac.jp/crid/1361412895388223360","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Efficacy and safety of empagliflozin as add‐on to insulin in Japanese patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled trial"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204245521280","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Comparison of the efficacy and safety of 10-mg empagliflozin every day versus every other day in Japanese patients with Type 2 Diabetes Mellitus: a pilot trial"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001206302482432","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Efficacy and safety of sodium-glucose cotransporter 2 inhibitors as add-on to metformin and sulfonylurea treatment for the management of type 2 diabetes: a meta-analysis"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.3109/07853890.2011.560181"},{"@type":"CROSSREF","@value":"10.2174/1570161116666180515154555_references_DOI_aFptaYiwtEaTLkGEEqOXz0BZTw3"},{"@type":"CROSSREF","@value":"10.1016/j.jdiacomp.2018.04.011_references_DOI_aFptaYiwtEaTLkGEEqOXz0BZTw3"},{"@type":"CROSSREF","@value":"10.1161/jaha.123.031805_references_DOI_aFptaYiwtEaTLkGEEqOXz0BZTw3"},{"@type":"CROSSREF","@value":"10.1507/endocrj.ej17-0372_references_DOI_aFptaYiwtEaTLkGEEqOXz0BZTw3"},{"@type":"CROSSREF","@value":"10.4137/dti.s31710_references_DOI_aFptaYiwtEaTLkGEEqOXz0BZTw3"},{"@type":"CROSSREF","@value":"10.1007/s00125-015-3650-4_references_DOI_aFptaYiwtEaTLkGEEqOXz0BZTw3"},{"@type":"CROSSREF","@value":"10.1101/2021.05.10.443537_references_DOI_aFptaYiwtEaTLkGEEqOXz0BZTw3"},{"@type":"CROSSREF","@value":"10.1016/j.diagmicrobio.2021.115556_references_DOI_aFptaYiwtEaTLkGEEqOXz0BZTw3"},{"@type":"CROSSREF","@value":"10.1111/dom.13909_references_DOI_aFptaYiwtEaTLkGEEqOXz0BZTw3"},{"@type":"CROSSREF","@value":"10.2152/jmi.64.50_references_DOI_aFptaYiwtEaTLkGEEqOXz0BZTw3"}]}